OUR CLINICAL TRIALS
A phase 3, multicenter, randomized, open-label, active-controlled study of trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine Leer mas
European cooperative study of primary systemic therapy in women with operable breast cancer and T Leer mas
Translational Study Of Tumor Samples From DS8201- A-U301 and DS8201-A-U302 Trials Leer mas